Combination of adipose-derived mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes for protecting kidney from acute ischemia-reperfusion injury

International Journal of Cardiology

Volumn 216, Issue , 2016, Pages 173-185

  Lin, Kun Chen ^a   Yip, Hon Kan ^a,b,c   Shao, Pei Lin ^c   Wu, Shun Cheng ^d   Chen, Kuan Hung ^a   Chen, Yen Ta ^a   Yang, Chih Chao ^a   Sun, Cheuk Kwan ^e   Kao, Gour Shenq ^a   Chen, Sheng Yi ^a   Chai, Han Tan ^a   Chang, Chia Lo ^a   Chen, Chih Hung ^a   Lee, Mel S ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e I SHOU UNIVERSITY   (Taiwan)

Author keywords

Acute kidney ischemia reperfusion injury; Adipose derived mesenchymal stem cell; Exosome; Inflammation; Oxidative stress

Indexed keywords

ANGIOPOIETIN; BONE MORPHOGENETIC PROTEIN 2; CASPASE 3; CD31 ANTIGEN; CD68 ANTIGEN; CYCLOOXYGENASE 2; CYTOCHROME C; HISTONE H2AX; HISTONE H2AX GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; KIDNEY INJURY MOLECULE 1; MACROPHAGE MIGRATION INHIBITION FACTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; P CADHERIN; PODOCIN; PROTEIN BAX; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SMAD1 PROTEIN; SMAD3 PROTEIN; SMAD5 PROTEIN; SYNAPTOPODIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; BIOLOGICAL MARKER; CREATININE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DNA DAMAGE; EXOSOME; KIDNEY INJURY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; REPERFUSION INJURY; UREA NITROGEN BLOOD LEVEL; ADIPOSE TISSUE; ANIMAL; BLOOD; CELL CULTURE; CYTOLOGY; DISEASE MODEL; KIDNEY DISEASES; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT;

ADIPOSE TISSUE; ANIMALS; BIOMARKERS; BLOOD UREA NITROGEN; CELLS, CULTURED; CREATININE; DISEASE MODELS, ANIMAL; EXOSOMES; KIDNEY DISEASES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 84975321727     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.04.061     Document Type: Article

References (48)

1. M.H. Kim, S.O. Koh, E.J. Kim, J.S. Cho, and S.W. Na Incidence and outcome of contrast-associated acute kidney injury assessed with Risk, Injury, Failure, Loss, and End-stage kidney disease (RIFLE) criteria in critically ill patients of medical and surgical intensive care units: a retrospective study BMC Anesthesiol. 15 2015 23
2. C. Clec'h, D. Razafimandimby, M. Laouisset, F. Chemouni, and Y. Cohen Incidence and outcome of contrast-associated acute kidney injury in a mixed medical-surgical ICU population: a retrospective study BMC Nephrol. 14 2013 31
3. E.A. Hoste, G. Clermont, A. Kersten, R. Venkataraman, D.C. Angus, D. De Bacquer, and et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis Crit. Care 10 2006 R73
4. E. Seeliger, M. Sendeski, C.S. Rihal, and P.B. Persson Contrast-induced kidney injury: mechanisms, risk factors, and prevention Eur. Heart J. 33 2012 2007 2015
5. A. Wonnacott, S. Meran, B. Amphlett, B. Talabani, and A. Phillips Epidemiology and outcomes in community-acquired versus hospital-acquired AKI Clin. J. Am. Soc. Nephrol. 9 2014 1007 1014
6. S. Uchino, J.A. Kellum, R. Bellomo, G.S. Doig, H. Morimatsu, S. Morgera, and et al. Acute renal failure in critically ill patients: a multinational, multicenter study JAMA 294 2005 813 818
7. S.M. Bagshaw, K.B. Laupland, C.J. Doig, G. Mortis, G.H. Fick, M. Mucenski, and et al. Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study Crit. Care 9 2005 R700 R709
8. J.W. Pickering, M.T. James, and S.C. Palmer Acute kidney injury and prognosis after cardiopulmonary bypass: a meta-analysis of cohort studies Am. J. Kidney Dis. 65 2015 283 293
9. P. Der Mesropian, J. Othersen, D. Mason, J. Wang, A. Asif, and R.O. Mathew Community acquired acute kidney injury: a challenge and opportunity for primary care in kidney health Nephrology (Carlton) 2016
10. E.B. Tapper, A. Bonder, and A. Cardenas Preventing and treating acute kidney injury among hospitalized patients with cirrhosis and ascites: a narrative review Am. J. Med. 2015
11. R.S. Hotchkiss, G. Monneret, and D. Payen Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach Lancet Infect. Dis. 13 2013 260 268
12. S.M. Bagshaw, C. George, R. Bellomo, and A.D.M. Committee Early acute kidney injury and sepsis: a multicentre evaluation Crit. Care 12 2008 R47
13. S. Rajapakse, C. Rodrigo, A. Rajapakse, D. Kirthinanda, and S. Wijeratne Renal replacement therapy in sepsis-induced acute renal failure Saudi J. Kidney Dis. Transpl. 20 2009 553 559
14. R.A. Zager Gentamicin effects on renal ischemia/reperfusion injury Circ. Res. 70 1992 20 28
15. R.E. Ratych, and G.B. Bulkley Free-radical-mediated postischemic reperfusion injury in the kidney J. Free Radic. Biol. Med. 2 1986 311 319
16. S.A. Jin, S.K. Kim, H.J. Seo, J.Y. Jeong, K.T. Ahn, J.H. Kim, and et al. Beneficial effects of necrosis modulator, indole derivative NecroX-7, on renal ischemia-reperfusion injury in rats Transplant. Proc. 48 2016 199 204
17. J. Damman, M.R. Daha, W.J. van Son, H.G. Leuvenink, R.J. Ploeg, and M.A. Seelen Crosstalk between complement and Toll-like receptor activation in relation to donor brain death and renal ischemia-reperfusion injury Am. J. Transplant. 11 2011 660 669
18. T. Moriyama, Y. Kanmura, and S.G. Lindahl Atrial natriuretic peptide attenuation of renal ischemia-reperfusion injury after major surgery J. Surg. Res. 201 2016 213 218
19. S.L. Jones, and M.A. Devonald How acute kidney injury is investigated and managed in UK intensive care units - a survey of current practice Nephrol. Dial. Transplant. 28 2013 1186 1190
20. N.C.G.C. (UK) Acute Kidney Injury: Prevention, Detection and Management up to the Point of Renal Replacement Therapy 2013 Royal College of Physicians (UK) London
21. J. Joslin, H. Wilson, D. Zubli, N. Gauge, M. Kinirons, A. Hopper, and et al. Recognition and management of acute kidney injury in hospitalised patients can be partially improved with the use of a care bundle Clin. Med. (Lond) 15 2015 431 436
22. H. Zhao, M. Zhao, Y. Wang, F. Li, and Z. Zhang Glycyrrhizic acid attenuates sepsis-induced acute kidney injury by inhibiting NF-kappaB signaling pathway Evid. Based Complement. Alternat. Med. 2016 2016 8219287
23. Y. Li, D. Zhong, L. Lei, Y. Jia, H. Zhou, and B. Yang Propofol prevents renal ischemia-reperfusion injury via inhibiting the oxidative stress pathways Cell. Physiol. Biochem. 37 2015 14 26
24. Y.T. Chen, C.C. Yang, Y.Y. Zhen, C.G. Wallace, J.L. Yang, C.K. Sun, and et al. Cyclosporine-assisted adipose-derived mesenchymal stem cell therapy to mitigate acute kidney ischemia-reperfusion injury Stem Cell Res. Ther. 4 2013 62
25. H.H. Chen, K.C. Lin, C.G. Wallace, Y.T. Chen, C.C. Yang, S. Leu, and et al. Additional benefit of combined therapy with melatonin and apoptotic adipose-derived mesenchymal stem cell against sepsis-induced kidney injury J. Pineal Res. 57 2014 16 32
26. T. Thum, J. Bauersachs, P.A. Poole-Wilson, H.D. Volk, and S.D. Anker The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle J. Am. Coll. Cardiol. 46 2005 1799 1802
27. M. Maumus, D. Guerit, K. Toupet, C. Jorgensen, and D. Noel Mesenchymal stem cell-based therapies in regenerative medicine: applications in rheumatology Stem Cell Res. Ther. 2 2011 14
28. H.K. Yip, Y.C. Chang, C.G. Wallace, L.T. Chang, T.H. Tsai, Y.L. Chen, and et al. Melatonin treatment improves adipose-derived mesenchymal stem cell therapy for acute lung ischemia-reperfusion injury J. Pineal Res. 54 2013 207 221
29. M. Kox, and P. Pickkers Reply: mesenchymal stromal (stem) cell therapy: an emerging immunomodulatory strategy for the adjunctive treatment of sepsis Am. J. Respir. Crit. Care Med. 189 2014 364 365
30. H.H. Chen, C.L. Chang, K.C. Lin, P.H. Sung, H.T. Chai, Y.Y. Zhen, and et al. Melatonin augments apoptotic adipose-derived mesenchymal stem cell treatment against sepsis-induced acute lung injury Am. J. Transl. Res. 6 2014 439 458
31. J. Rossol-Allison, and C.J. Ward Exosomes to the rescue J. Am. Soc. Nephrol. 26 2015 2303 2304
32. C. Akyurekli, Y. Le, R.B. Richardson, D. Fergusson, J. Tay, and D.S. Allan A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles Stem Cell Rev. 11 2015 150 160
33. D. Burger, J.L. Vinas, S. Akbari, H. Dehak, W. Knoll, A. Gutsol, and et al. Human endothelial colony-forming cells protect against acute kidney injury: role of exosomes Am. J. Pathol. 185 2015 2309 2323
34. H.H. Chen, P.F. Lai, Y.F. Lan, C.F. Cheng, W.B. Zhong, Y.F. Lin, and et al. Exosomal ATF3 RNA attenuates pro-inflammatory gene MCP-1 transcription in renal ischemia-reperfusion J. Cell. Physiol. 229 2014 1202 1211
35. Y. Zhou, H. Xu, W. Xu, B. Wang, H. Wu, Y. Tao, and et al. Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro Stem Cell Res. Ther. 4 2013 34
36. X. Zou, G. Zhang, Z. Cheng, D. Yin, T. Du, G. Ju, and et al. Microvesicles derived from human Wharton's jelly mesenchymal stromal cells ameliorate renal ischemia-reperfusion injury in rats by suppressing CX3CL1 Stem Cell Res. Ther. 5 2014 40
37. S.V. Fleig, and B.D. Humphreys Rationale of mesenchymal stem cell therapy in kidney injury Nephron Clin. Pract. 127 2014 75 80
38. A. Dorronsoro, and P.D. Robbins Regenerating the injured kidney with human umbilical cord mesenchymal stem cell-derived exosomes Stem Cell Res. Ther. 4 2013 39
39. M.W. Chang, C.H. Chen, Y.C. Chen, Y.C. Wu, Y.Y. Zhen, S. Leu, and et al. Sitagliptin protects rat kidneys from acute ischemia-reperfusion injury via upregulation of GLP-1 and GLP-1 receptors Acta Pharmacol. Sin. 36 2015 119 130
40. S.F. Ko, H.K. Yip, Y.Y. Zhen, C.C. Lee, C.C. Lee, C.C. Huang, and et al. Adipose-derived mesenchymal stem cell exosomes suppress hepatocellular carcinoma growth in a rat model: apparent diffusion coefficient, natural killer T-cell responses, and histopathological features Stem Cells Int. 2015 2015 853506
41. H.K. Yip, C.C. Yang, K.H. Chen, T.H. Huang, Y.L. Chen, Y.Y. Zhen, and et al. Combined melatonin and exendin-4 therapy preserves renal ultrastructural integrity after ischemia-reperfusion injury in the male rat J. Pineal Res. 59 2015 434 447
42. Y.T. Chen, H.J. Chiang, C.H. Chen, P.H. Sung, F.Y. Lee, T.H. Tsai, and et al. Melatonin treatment further improves adipose-derived mesenchymal stem cell therapy for acute interstitial cystitis in rat J. Pineal Res. 57 2014 248 261
43. C.L. Chang, P.H. Sung, C.K. Sun, C.H. Chen, H.J. Chiang, T.H. Huang, and et al. Protective effect of melatonin-supported adipose-derived mesenchymal stem cells against small bowel ischemia-reperfusion injury in rat J. Pineal Res. 59 2015 206 220
44. J.M. Lambert, E.F. Lopez, and M.L. Lindsey Macrophage roles following myocardial infarction Int. J. Cardiol. 130 2008 147 158
45. N.G. Frangogiannis The immune system and cardiac repair Pharmacol. Res. 58 2008 88 111
46. J.J. Sheu, S. Chua, C.K. Sun, L.T. Chang, C.H. Yen, C.J. Wu, and et al. Intra-coronary administration of cyclosporine limits infarct size, attenuates remodeling and preserves left ventricular function in porcine acute anterior infarction Int. J. Cardiol. 147 2011 79 87
47. T.H. Huang, Y.T. Chen, P.H. Sung, H.J. Chiang, Y.L. Chen, H.T. Chai, and et al. Peripheral blood-derived endothelial progenitor cell therapy prevented deterioration of chronic kidney disease in rats Am. J. Transl. Res. 7 2015 804 824
48. F.Y. Lee, Y.L. Chen, P.H. Sung, M.C. Ma, S.N. Pei, C.J. Wu, and et al. Intracoronary transfusion of circulation-derived CD34 + cells improves left ventricular function in patients with end-stage diffuse coronary artery disease unsuitable for coronary intervention Crit. Care Med. 43 2015 2117 2132